Chemotherapeutic medicines can either be used alone or in combination with other treatments to treat prostate cancer. These medications are administered orally or intravenously. The following medications have been approved to treat prostate cancer:
Abiraterone Acetate is a medication used to treat metastasized and high-risk prostate cancer in combination with prednisone. It is especially beneficial for patients who are both castration-resistant and sensitive to castration.
Apalutamide is a drug that is used to treat localised prostate cancer, especially in patients who are castration-resistant but have not yet developed metastases.
Bicalutamide is a medication that is licenced for the treatment of metastasized prostate cancer and is frequently used in conjunction with hormone therapy.
Cabazitaxel is a medication used to treat individuals with metastasized prostate cancer who are castration-resistant or have already had chemotherapy.
It is frequently prescribed in conjunction with prednisone.
This medicine is used to treat localised and advanced prostate cancer as an androgen suppressant.
Docetaxel is a medication that has been approved for use alone or in combination with other treatments to treat metastasized prostate cancer that has failed to respond to hormone therapy.
This drug is advised as an androgen suppression therapy for localised and advanced prostate cancer. This medicine is given to patients as part of palliative treatment to help them cope with the symptoms of prostate cancer.
Enzalutamide is a medication that is approved to treat castration-resistant prostate cancer.
Flutamide is a medication that has been approved for the treatment of all kinds of prostate cancer. It's frequently taken with luteinizing, a hormone-releasing agonist.
Goserelin acetate is a medication that can be used in conjunction with radiotherapy to treat localised prostate cancer. It is also utilised in palliative care.
This medicine has been licenced for palliative care in the treatment of advanced prostate cancer that has not responded to hormone therapy.
Nilutamide is a medication that is used to treat people who have had an orchiectomy and have metastasized prostate cancer.
Sipuleucel-T is a medication that is used to treat prostate cancer that has spread. It's also indicated for people who haven't demonstrated any signs or symptoms of cancer or who haven't seen any progress with hormone therapy.
Radium 223 dichloride
This medicine has been approved for the treatment of castration-resistant prostate cancer. Patients with cancer that has metastasized to the bones and is causing symptoms of spreading to other parts of the body are also advised to take it.